Slow, costly process stymies generic biotech drugs (Reuters)

[unable to retrieve full-text content]Reuters - One of the pledges of the Obama administration's healthcare overhaul was to enable cheaper copies of expensive biotech drugs, but the savings may not be as deep or come as quickly as hoped.

Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http%3A//news.yahoo.com/s/nm/20120305/hl_nm/us_biosimilars

widespread panic widespread panic richard stallman richard stallman williston north dakota williston north dakota kody brown